|
medpundit |
||
 |
 |
|
Saturday, March 15, 2003The one that comes first to my mind is the CellPro Ceprate, which was taken off the market by Baxter via an IP lawsuit. As I have watched technology and medicine I think an equally if not more interesting question is: How many drugs/technologies are kept of the shelves by companies seeking to protect their current market/therapy? I know that some large medical/biotech companies act in ways which one could come to such a conclusion. They buy up or otherwise seek to legally obstruct new companies and technologies so that their current product is protected and the market they enjoy is not threatened. My suspicion is that at least as many products are kept off the market in this manner as are kept off by the fact that the inventor (a basic researcher or physician) is unable to foresee or uninterested in developing the clinical application of his invention. We do an awful lot of research that if we could only see the potential applications, we would be decades ahead of where we are today. Interesting. posted by Sydney on 3/15/2003 07:42:00 AM 0 comments 0 Comments: |
|
